Register for OBR daily


To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

IMNP $3.60 0.3300 +10.09%
CBMG $21.16 1.0600 +5.27%
NWBO $5.86 0.2900 +5.21%
OHRP $8.28 0.3900 +4.94%
MYGN $38.01 1.6100 +4.42%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PARD $0.20 -0.0989 -33.09%
ENZN $1.30 -0.1300 -9.09%
AVEO $1.11 -0.0900 -7.50%
EXEL $1.62 -0.1200 -6.90%
CVM $0.92 -0.0617 -6.31%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | Next > | Last >>

Houston’s Bellicum Nets $55M to Boost Trials For Cancer Treatment

(Xconomy Texas) Aug 27, 2014 - Houston biotech firm Bellicum Pharmaceuticals announced Wednesday it has raised $55 million in a Series C financing.
read article 

The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine

(LLS) Aug 28, 2014 - The Leukemia & Lymphoma Society (LLS) and OncoPep have entered a partnership to advance an experimental cancer vaccine to treat patients with smoldering multiple myeloma (SMM), an asymptomatic stage of myeloma.
read press release 

ERYTECH Announces Second Positive DSMB Review of Its Phase IIb Study in Acute Myeloid Leukemia

(Yahoo! Finance) Aug 27, 2014 - ERYTECH Pharma announces that an independent Data and Safety Monitoring Board (DSMB) completed its second safety assessment of the company’s Phase IIb study in Acute Myeloid Leukemia (AML) and unanimously recommended continuation of the trial without modification.
read article 

Pilot Program Aims to Improve Colorectal Cancer Screening Rates, Access to Specialty Care in Community Health Centers

(ACS) Aug 27, 2014 - Three locations will each receive $100,000 in funding to launch pilot programs to improve colorectal cancer screening rates and follow-up care for patients served by community health centers.
read press release 

New Tool Clarifies Drug Reimbursement For Cancer Patients

(Medscape Medical News) Aug 27, 2014 - A new tool that evaluates insurance coverage for specific cancer therapies might be useful for oncologists and their patients weighing different treatment options.
read article (free registration required) 

Rinse Eases Symptoms of Oral Mucositis in Cancer Patients

(Medscape Medical News) Aug 27, 2014 - A rinse for oral mucositis has been shown to offer significantly better symptom improvement than placebo in a randomized controlled trial.
read article (free subscription required) 

Risk of Diabetes Up in Hodgkin’s Lymphoma Survivors

(Doctors Lounge/HealthDay News) Aug 27, 2014 - Para-aortic radiation correlates with increased diabetes mellitus risk for Hodgkin's lymphoma survivors, according to a study published online Aug. 25 in the Journal of Clinical Oncology.
read article 

The Thunder God Vine, Assists by Nanotechnology, Could Shake Up Future Cancer Treatment

(Institute for Basic Science [Korea]) Aug 21, 2014 - Hepatocellular carcinoma (HCC) is the second leading cause of cancer-associated death worldwide.
read press release 

Light Therapy For Precancerous Skin Lesions

(WebMD/HealthDay News) Aug 27, 2014 - Treating pre-cancerous skin spots with a type of light therapy may be more effective than the usual therapy -- freezing the lesions with liquid nitrogen, a new study suggests.
read article 

Do More for Depressed Cancer Patients – Study

(The Guardian [UK]) Aug 27, 2014 - Three-quarters of cancer patients who also have clinical depression are not currently receiving any treatment for depression, a study has found.
read article 

Drug Shows Promise For Subset of Stage III Colon Cancer Patients

(AGA) Aug 28, 2014 - A subset of patients with stage III colon cancer had improved survival rates when treated with irinotecan-based therapy, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.
read press release 

Study Questions Surveillance Colonoscopy

(MedPage Today/The Gupta Guide) Aug 27, 2014 - Removal of adenomatous polyps -- without follow-up surveillance colonoscopy -- led to a colorectal-cancer mortality similar to that of the general population, results of a large Norwegian cohort study showed.
read article (free registration required) 

Cancer Drugs Fund Subject to 'Value For Money' Assessment For First Time

(The Telegraph [UK]) Aug 28, 2014 - David Cameron's flagship cancer drugs fund receives an £80million boost but clinicians will assess whether treatments represent value for money for the first time.
read article 

FDA Lifts Partial Hold on OncoMed's Cancer Drug Trials

(Reuters) Aug 28, 2014 - OncoMed Pharmaceuticals Inc said the U.S. Food and Drug Administration lifted a partial hold on patient enrolments for three trials testing its experimental cancer drug, vantictumab.
read article 

UK Cancer Drug Fund Gets Extra 160 Million Pounds

(Reuters) Aug 28, 2014 - A fund that helps patients receive cancer medicines not routinely paid for by Britain's state health service is to get an extra 160 million pounds ($265 million), although the government is also taking a tougher line on prices.
read article 

Allergan Sets Dec. 18 Shareholder Vote in Valeant Takeover Fight

(Washington Post/Bloomberg) Aug 27, 2014 - Allergan Inc. shareholders will get the chance to vote on Dec. 18 whether to replace members of the drugmaker’s board as part of a $54 billion hostile takeover fight with Valeant Pharmaceuticals International Inc.
read article (free registration required) 

Pharma Tells the Federal Government: Transparency Works Both Ways

(Wall Street Journal/Pharmalot blog) Aug 26, 2014 - File this under ‘how ironic.’ Drug makers are asking for more transparency from the government agency that is requiring them to be more transparent about how much they pay doctors.
read article (paid subscription required) 

Amgen Heart Failure Drug Gets Priority Designation From FDA

(Wall Street Journal) Aug 27, 2014 - Amgen Inc. said U.S. regulators have granted a priority review designation for the company's new drug application for its prospective heart-failure treatment.
read article (paid subscription required) 

Nonprofit Hospitals’ 2013 Revenue Lowest Since Recession, Report Says

(New York Times) Aug 27, 2014 - Nonprofit hospitals last year had their worst financial performance since the Great Recession, according to a report released on Wednesday.
read article 

New Report About HPV Vaccine Trials Released

(UICC [Geneva, Switzerland]) Aug 25, 2014 - A new report from a Working Group convened by the International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization, and the United States National Cancer Institute (NCI) shows how the evaluation and licensing of prophylactic human papillomavirus (HPV) vaccines could be significantly accelerated.
read press release 

Cancer Genetics' Proprietary Genomic Diagnostic Tests Added to National Institutes of Health's Genetic Testing Registry

(CNN Money) Aug 27, 2014 - Cancer Genetics, Inc. announced today that the National Institutes of Health's (NIH) Genetic Testing Registry now features the company's proprietary diagnostic and prognostic genomic tests.
read article 

Five Things You Need To Know About Blood Cancers And One Thing You Can Do

(Yahoo! Finance) Aug 27, 2014 - Every three minutes, someone in the U.S. is diagnosed. More than 1.1 million Americans are living with, or in remission from, these diseases.
read article 

Innate Pharma: Orphan Drug Designation In The European Union For IPH4102

(CNBC) Aug 27, 2014 - Innate Pharma SA today announced that the European Commission has granted orphan drug designation to IPH4102 for the treatment of cutaneous T-cell lymphoma (CTCL).
read article 

Herbert Irving Comprehensive Cancer Center Has Designation Renewed by National Cancer Institute; Awarded $18M Grant

(CUMC) Aug 27, 2014 — Outstanding basic research, a growing focus on translating discoveries into treatments, and a dedication to patient care have earned the Herbert Irving Comprehensive Cancer Center (HICCC) of Columbia University Medical Center (CUMC) and NewYork-Presbyterian Hospital an $18 million, five-year Cancer Center Support Grant from the National Cancer Institute (NCI).
read press release 

Fighting Prostate Cancer with a Tomato-rich Diet

(University of Bristol [UK]) Aug 27, 2014 - Men who eat over 10 portions a week of tomatoes have an 18 percent lower risk of developing prostate cancer, new research suggests.
read press release